NYSE:HLI - Houlihan Lokey Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $64.25
  • Forecasted Upside: -1.35 %
  • Number of Analysts: 5
  • Breakdown:
  • 2 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$65.13
▼ -0.16 (-0.25%)
1 month | 3 months | 12 months
Get New Houlihan Lokey Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HLI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HLI

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$64.25
▼ -1.35% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Houlihan Lokey in the last 3 months. The average price target is $64.25, with a high forecast of $77.00 and a low forecast of $57.00. The average price target represents a -1.35% upside from the last price of $65.13.
Hold
The current consensus among 5 contributing investment analysts is to hold stock in Houlihan Lokey. This rating has held steady since November 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/12/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/11/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/10/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/8/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
9/6/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
12/5/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
2/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings
3/5/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/29/2021Morgan StanleyLower Price TargetUnderweight$80.00 ➝ $77.00High
i
1/5/2021Wolfe ResearchDowngradePeer Perform ➝ Underperform$57.00 ➝ $63.00N/A
i
Rating by Steven Chubak at Wolfe Research
12/16/2020Seaport Global SecuritiesInitiated CoverageNeutralN/A
i
Rating by J. Mitchell at Seaport Global Securities
12/14/2020Morgan StanleyDowngradeEqual Weight ➝ Underweight$80.00High
i
10/12/2020Morgan StanleyBoost Price TargetEqual Weight$62.00 ➝ $65.00Low
i
10/2/2020UBS GroupDowngradeBuy ➝ Neutral$60.00Medium
i
7/22/2020Wolfe ResearchInitiated CoveragePeer Perform$60.00Medium
i
7/10/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$66.00 ➝ $57.00Medium
i
5/13/2020Morgan StanleyBoost Price TargetEqual Weight$58.00 ➝ $62.00High
i
5/13/2020UBS GroupBoost Price TargetBuy$55.00 ➝ $66.00High
i
4/9/2020Morgan StanleyBoost Price TargetEqual Weight$52.00 ➝ $58.00Low
i
3/25/2020UBS GroupLower Price TargetBuy$59.00 ➝ $55.00Medium
i
1/26/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$52.00 ➝ $53.00Low
i
1/13/2020Buckingham ResearchBoost Price TargetBuy$51.00 ➝ $57.00High
i
11/27/2019Morgan StanleyInitiated CoverageEqual Weight$49.00N/A
i
11/20/2019Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$49.00Low
i
7/11/2019Buckingham ResearchLower Price TargetBuy$53.00 ➝ $51.00Low
i
5/23/2019JMP SecuritiesDowngradeOutperform ➝ Market Perform$46.65High
i
4/3/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$44.00 ➝ $52.00Low
i
1/9/2019Bank of AmericaUpgradeNeutral ➝ Buy$46.00 ➝ $47.00High
i
1/4/2019Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Outperform$47.00Medium
i
11/6/2018The Goldman Sachs GroupInitiated CoverageNeutral$46.00Medium
i
10/8/2018UBS GroupLower Price TargetBuy ➝ Buy$57.00 ➝ $55.00Medium
i
8/2/2018Sandler O'NeillReiterated RatingHold$52.00Low
i
7/27/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $57.00High
i
6/26/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$50.00 ➝ $55.00Low
i
4/5/2018Buckingham ResearchInitiated CoverageBuy$54.00Medium
i
1/30/2018Bank of AmericaBoost Price TargetNeutral ➝ Neutral$50.00 ➝ $52.00Low
i
1/11/2018Keefe, Bruyette & WoodsReiterated RatingBuy$52.00Medium
i
12/22/2017Keefe, Bruyette & WoodsReiterated RatingBuy$49.00Low
i
10/25/2017Bank of AmericaBoost Price TargetNeutral$40.00 ➝ $44.00N/A
i
10/25/2017UBS GroupBoost Price TargetBuy$44.00 ➝ $47.00N/A
i
10/3/2017Keefe, Bruyette & WoodsReiterated RatingBuyLow
i
9/12/2017JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$42.00High
i
8/27/2017Keefe, Bruyette & WoodsReiterated RatingBuy$40.00Low
i
7/27/2017Keefe, Bruyette & WoodsReiterated RatingBuy$40.00Low
i
7/26/2017UBS GroupReiterated RatingBuy$40.00 ➝ $42.00Medium
i
6/14/2017Keefe, Bruyette & WoodsReiterated RatingBuy$38.00Low
i
5/11/2017Bank of AmericaDowngradeBuy ➝ Neutral$36.00 ➝ $38.00High
i
4/7/2017JMP SecuritiesReiterated RatingOutperform$34.00 ➝ $36.00Low
i
12/14/2016Bank of AmericaReiterated RatingBuyN/A
i
9/23/2016Keefe, Bruyette & WoodsReiterated RatingOutperform$28.00N/A
i
8/18/2016Sandler O'NeillDowngradeBuy ➝ HoldN/A
i
8/4/2016UBS GroupReiterated RatingBuy$27.00N/A
i
(Data available from 3/6/2016 forward)
Houlihan Lokey logo
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial Advisory Services. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as financial sponsors on various transactions. It also provides financing solutions and capital-raising advisory services for publicly-held and multinational corporations, financial sponsors, and privately-held companies. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial Advisory Services segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution consulting services. It serves corporations, financial sponsors, and government agencies. The company was founded in 1972 and is headquartered in Los Angeles, California.
Read More

Today's Range

Now: $65.13
$64.26
$66.21

50 Day Range

MA: $67.07
$63.56
$71.69

52 Week Range

Now: $65.13
$42.86
$73.26

Volume

746,030 shs

Average Volume

409,654 shs

Market Capitalization

$4.49 billion

P/E Ratio

21.42

Dividend Yield

2.03%

Beta

0.68

Frequently Asked Questions

What sell-side analysts currently cover shares of Houlihan Lokey?

The following sell-side analysts have issued research reports on Houlihan Lokey in the last twelve months: JPMorgan Chase & Co., Morgan Stanley, Seaport Global Securities, UBS Group AG, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for HLI.

What is the current price target for Houlihan Lokey?

4 Wall Street analysts have set twelve-month price targets for Houlihan Lokey in the last year. Their average twelve-month price target is $64.25, suggesting a possible downside of 1.4%. Morgan Stanley has the highest price target set, predicting HLI will reach $77.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $57.00 for Houlihan Lokey in the next year.
View the latest price targets for HLI.

What is the current consensus analyst rating for Houlihan Lokey?

Houlihan Lokey currently has 2 sell ratings and 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HLI, but not buy more shares or sell existing shares.
View the latest ratings for HLI.

What other companies compete with Houlihan Lokey?

How do I contact Houlihan Lokey's investor relations team?

Houlihan Lokey's physical mailing address is 10250 CONSTELLATION BLVD. 5TH FLOOR, LOS ANGELES CA, 90067. The financial services provider's listed phone number is 310-788-5200 and its investor relations email address is [email protected] The official website for Houlihan Lokey is www.hl.com.